Amendment · Form C/A

An amendment to an offering — the company changed its terms or corrected its filing.

Rejuve Biotech Inc.

rejuve.bio · DE · Filed Sep 13, 2024

Rejuve Biotech Inc. filed a Form C/A — amendment — with the SEC on Sep 13, 2024. The Regulation Crowdfunding offering seeks $10,004, up to a maximum of $4,999,999 on Netcapital. Investors receive: Common Stock at $8.33. The offering closes Jun 12, 2024.

Target raise	$10,004
Maximum raise	$4,999,999
Security	Common Stock @ $8.33
Closes	Jun 12, 2024
Portal	Netcapital

Filing documents

OFFERING STATEMENT PDF PDF · 359 KB ↗ OFFERING PAGE JPG Image · 1.7 MB ↗ CPA AUDIT REPORT PDF · 454 KB ↗ CERTIFICATE OF INCORPORATION PDF · 1020 KB ↗ CORPORATE BYLAWS PDF · 55 KB ↗ ADDITIONAL INFORMATION PDF · 154 KB ↗

View the official filing on SEC EDGAR →

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.